• Research/Demonstration Projects: Belgium has an ongoing PrEP demonstration project for MSMs, the “Be PrEPared-The Antwerp PrEP project”.
  • Drug Registration: Currently, Gilead (the manufacturer of Truvada) has not applied to the Belgium regulatory agency for a prevention indication. The European Medicines Agency is in the process of reviewing Truvada for PrEP. The Agency is responsible for the scientific evaluation of medicines developed by pharmaceutical companies for use in the European Union, but each member state will separately determine how, if at all, it might introduce PrEP.
  • Policy/Regulatory: There is no national policy or guidance at present.
  • Advocacy: If you’re a Belgian advocate working on PrEP, building a campaign or seeking to share insights and experience, please send info here and PrEPWatch will post it.

News Spotlight